Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Life360, Inc. Director's Dealing 2022

Jun 27, 2022

30724_rns_2022-06-27_b6538d45-64e6-4bc3-a9e9-1ac183678291.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number:
3235-0104
Estimated average burden hours
per response...
0.5

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

==> picture [708 x 270] intentionally omitted <==

----- Start of picture text -----

1. Name and Address of Reporting Person 2. Date of Event Requiring 3. Issuer Name and Ticker or Trading Symbol
Synge James Statement (Month/Day/Year) Life360, Inc. [360.AX]
06/27/2022
(Last) (First) (Middle) 4. Relationship of Reporting Person(s) to 5. If Amendment, Date Original
c/o Life360, Inc., 539 Bryant Street, Suite Issuer Filed(Month/Day/Year)
(Check all applicable)
402
X Director _ 10% Owner
(Street)
Officer (give title_ Other (specify 6. Individual or Joint/Group Filing (Check
San below) below) Applicable Line)
Francisco CA 94107 X Form filed by One Reporting Person
Form filed by More than One
(City) (State) (Zip) Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security 2. Amount of Securities Beneficially 3. Ownership 4. Nature of Indirect Beneficial Ownership
(Instr. 4) Owned Form: Direct (D) (Instr. 5)
(Instr. 4) or Indirect (I)
(Instr. 5)
Common Stock 501,815 (1) D
Common Stock 64,379 (2) I Held by ICCA Labs, LLC (3)
Held by Stynge Pty Ltd ATF Sandy Bay
Common Stock 70,573 (4) I Trust (5)
----- End of picture text -----

Page 1 of 4.

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security
(Instr. 4)
2. Date Exercisable and
Expiration Date
(Month/Day/Year)
2. Date Exercisable and
Expiration Date
(Month/Day/Year)
3. Title and Amount of Securities
Underlying Derivative Security
(Instr. 4)
3. Title and Amount of Securities
Underlying Derivative Security
(Instr. 4)
4. Conversion or
Exercise Price of
Derivative
Security
5. Ownership
Form of
Derivative
Security: Direct
(D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial
Ownership
(Instr. 5)
Date
Exercisable
Expiration
Date
Title Amount or Number
of Shares
Stock Option (right to buy) (6) D
04/29/2031 Common
Sk
12,203 $ 13.35
toc
Stock Option (right to buy) (7) D
05/20/2032 Common
Sk
15,794 $ 8.19
toc

Explanation of Responses:

  • (1) Includes 480,347 shares of the Issuer's common stock underlying 1,441,041 Chess Depositary Interests ("CDIs"). The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Also includes 4,581 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

  • (2) Represents shares of the Issuer's common stock underlying 193,137 CDIs.

  • (3) The Reporting Person has shared investment control over Carthona Capital FS Pty Ltd. ("Carthona Capital"). Carthona Capital is a member of ICCA Labs, LLC, an entity that holds an aggregate of 133,408 shares of the Issuer's common stock underlying 400,224 CDIs. The number of shares reported herein represents Carthona Capital's proportionate ownership interest in ICCA Labs, LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

  • (4) Represents shares of the Issuer's common stock underlying 211,720 CDIs.

  • (5) The Reporting Person has shared investment control of Stynge Pty Ltd ATF Sandy Bay Trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

  • (6) The stock option is fully vested and exercisable.

  • (7) The stock option vests and becomes exercisable as to 1/4th of the total number of shares in equal quarterly installments beginning on August 15, 2022, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.

/s/ Daniel Menudier, as Attorney-in-Fact 06/27/2022 **Signature of Reporting Person Date

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).

Page 2 of 4.

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.

Page 3 of 4.

POWER OF ATTORNEY

The undersigned as a Section 16 reporting person of Life360, Inc. (the "Company"), hereby constitutes and appoints Russell J. Burke, Kirsten Daru and Daniel Menudier, and each of them, the undersigned's true and lawful attorney-in-fact to:

(1) execute, deliver and file for and on behalf of the undersigned, in the undersigned's capacity as an officer and/or director of the Company, Forms 3, 4, and 5 in accordance with Section 16(a) of the Exchange Act;

(2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or 5, complete and execute any amendment or amendments thereto, and timely file such form with the SEC and any stock exchange or similar authority;

(3) seek or obtain, as the undersigned's representative and on the undersigned's behalf, information on transactions in the Company's securities from any third party, including brokers, employee benefit plan administrators and trustees, and the undersigned hereby authorizes any such person to release any such information to the undersigned and approves and ratifies any such release of information; and

(4) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion.

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Exchange Act. The undersigned further acknowledges and agrees that the attorney-in-fact and the Company are relying on written and oral information provided by the undersigned to complete such forms and the undersigned is responsible for reviewing the completed forms prior to their filing. The attorney-in-fact and the Company are not responsible for any errors or omissions in such filings. The attorney-in-fact and the Company are not responsible for determining whether or not the transactions reported could be matched with any other transactions for the purpose of determining liability for short-swing profits under Section 16(b).

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the Company and the foregoing attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of 5/25/2022. /s/ James Synge

Name: James Synge

Page 4 of 4.